Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib plus vinorelbine in advanced breast cancer
2005-001537-15Phase 2Completed
- Sponsor
- Novartis
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib and vinorelbine in breast cancer, sponsored by Novartis. Primary endpoints: Safety and tolerability, Clinical response rate and 3 more. Started Oct 2005; status: completed.
02
Drugs
imatinibvinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-001537-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001537-15.